Company intelligence / Profile preview

MicroMed Cardiovascular

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

MicroMed Cardiovascular developed miniaturized ventricular assist devices (VADs), particularly the DeBakey VAD and its modern iteration HeartAssist 5. The DeBakey VAD became the first device of its kind used in humans in 1998 and has been implanted more than 440 times worldwide. The HeartAssist 5 is an axial flow device with a direct flow measurement system and cellular-based remote monitoring capabilities. The device is approved in Europe and authorized in the U.S. for pediatric use (ages 5-16) as a bridge to transplantation.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

NASA (DeBakey VAD development partnership)

Beyond the preview

Go deeper on MicroMed Cardiovascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroMed Cardiovascular.

Explore the full profile